Dr. Wayne Clark
Add to your Care-Team
Dr. Wayne Clark
Dr. Wayne Clark
I specialize in
I have been in practice
My answers and insights have
Helped 20 people
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I was educated and trained at
Medical / Graduate School
Oregon Health & Science University School of Medicine
Stroke after Carotid Stenting and Endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).
Circulation., Nov (2012)
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.
Lancet Neurol., Nov;11(11):942-50 (2012)
Stroke: Treatment for acute stroke--the end of the citicoline saga.
Nat Rev Neurol., Sep;8(9):484-5 (2012)
Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
Stroke., Sep;43(9):2408-16 (2012)
Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion.
J Neurointerv Surg., Jun;3(2):151-5 (2011)
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial).
J. Am. Coll. Cardiol., Oct;58(15):1557-65 (2011)
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomy.
Stroke., Oct;42(10):2720-1 (2011)
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke.
Stroke., Sep;42(9):2633-5 (2011)
Drug eluting stents for symptomatic intracranial and vertebral artery stenosis.
Interv Neuroradiol., Jun;17(2):241-7 (2011)
Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
Stroke., Mar;42(3):675-80 (2011)
Carotid stenting vs surgery: parsing the risk of stroke and MI.
Cleve Clin J Med., Dec;77(12):892-902 (2010)
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.
Stroke., Oct;41(10):2283-7 (2010)
Stenting versus endarterectomy for treatment of carotid-artery stenosis.
N. Engl. J. Med., Jul;363(1):11-23 (2010)
Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optisonâ„¢ & SonoVue(Â®)).
J. Thromb. Thrombolysis., Jan;31(1):71-84 (2011)
Indications and applications of arterial stents for stroke prevention in atherosclerotic intracranial stenosis.
Curr Cardiol Rep., Jan;12(1):20-8 (2010)
Efficacy of citicoline as an acute stroke treatment.
Expert Opin Pharmacother., Apr;10(5):839-46 (2009)
Keep the three hour TPA window: the lost study of Atlantis.
J Stroke Cerebrovasc Dis., Jan;18(1):78-9 (2009)
Benign angioedema after thrombolysis for acute stroke.
J Stroke Cerebrovasc Dis., 9(2):79-81 (2000 Mar-Apr)
Adiponectin: spectator or player?
Stroke., Sep;36(9):1919-20 (2005)
Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra).
Neurology., Mar;64(6):1095-6 (2005)
Persistent inflammatory response in stroke survivors.
Neurology., Jun;50(6):1722-8 (1998)
Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat.
J. Mol. Neurosci., Oct;9(2):103-8 (1997)
Antileukocyte adhesion therapy: preclinical trials and combination therapy.
Neurology., Nov;49(5 Suppl 4):S32-8 (1997)
Cytokines and reperfusion injury.
Neurology., Nov;49(5 Suppl 4):S10-4 (1997)
A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
Neurology., Sep;49(3):671-8 (1997)
Rotational vertebral artery occlusion: a mechanism of vertebrobasilar insufficiency.
Neurosurgery., Aug;41(2):427-32; discussion 432-3 (1997)
Homozygous hereditary resistance to activated protein C presenting as cerebral venous thrombosis.
J Stroke Cerebrovasc Dis., 6(5):370-2 (1997 Jul-Aug)
The therapeutic potential of anti-cytokine strategies in central nervous system ischaemia.
Expert Opin Investig Drugs., Apr;6(4):407-15 (1997)
Intracranial intraarterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery.
J. Neurosurg., Mar;84(3):387-92 (1996)
Endovascular treatment for acute and chronic brain ischemia.
Curr. Opin. Neurol., Feb;9(1):62-7 (1996)
Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia.
Mol. Chem. Neuropathol., Dec;26(3):213-30 (1995)
Lazaroids. CNS pharmacology and current research.
Drugs., Dec;50(6):971-83 (1995)
Spontaneous early improvement following ischemic stroke.
Stroke., Aug;26(8):1358-60 (1995)
Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis.
Stroke., Jul;26(7):1200-4 (1995)
Interleukin-6 and interleukin-1 receptor antagonist in acute stroke.
Ann. Neurol., Jun;37(6):800-5 (1995)
The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats.
J. Mol. Neurosci., 6(1):43-50 (1995)
Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial.
Crit. Care Med., Jul;22(7):1161-6 (1994)
Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment.
Stroke., Jul;25(7):1411-5; discussion 1416 (1994)
Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease.
Heart Dis Stroke., 2(6):503-6 (1993 Nov-Dec)
Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate antagonists in rabbits.
Stroke., Jul;24(7):1068-71 (1993)
Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke.
J. Neuroimmunol., Apr;44(1):123-5 (1993)
Neutrophil adhesion in central nervous system ischemia in rabbits.
Brain Behav. Immun., Mar;7(1):63-9 (1993)
Abnormalities of hemostasis in ischemic stroke.
Med. Clin. North Am., Jan;77(1):77-94 (1993)
Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.
Stroke., Mar;23(3):388-93 (1992)
Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia.
J. Neurosurg., Jan;76(1):106-10 (1992)
Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule.
J. Neurosurg., Oct;75(4):623-7 (1991)
Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
Stroke., Jul;22(7):872-6 (1991)
Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment.
Stroke., Jul;22(7):877-83 (1991)
Effect of protein kinase C modulation on outcome of experimental CNS ischemia.
Brain Res., May;547(2):193-8 (1991)
Detection of arterial emboli using Doppler ultrasound in rabbits.
Stroke., Feb;22(2):253-8 (1991)
Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury.
Brain Res., Dec;537(1-2):256-62 (1990)
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
Stroke., Nov;21(11):1589-93 (1990)
Dr. Wayne Clark M